Clinical Trial Update: Prospective Randomized Endovascular Therapy in Multiple Sclerosis - PREMiSE [NA]

View source ↗

Summary

The PREMiSE trial, a prospective randomized study of endovascular therapy for multiple sclerosis, has completed and posted results on 2025-06-18.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Multiple Sclerosis | NA | Status: COMPLETED | Results posted: 2025-06-18